Insugen-N Dosage & Drug Information

Concise Prescribing Info

Contents

Isophane insulin (rDNA origin)

Indications/Uses

DM.

Dosage/Direction for Use

Individualized dosage. 0.3-1 IU/kg daily.

Contraindications

Hypersensitivity. Hypoglycaemia.

Special Precautions

Hyperglycaemia. Type 1 DM. Activity or diet changes. Transfer to another type or brand of insulin should be done under medical supervision. Inj site reactions. May affect ability to drive or operate machinery. Renal or hepatic impairment. Insulin requirement changes during pregnancy.

Adverse Reactions

Hypoglycaemia. Acute painful neuropathy. Temporary worsening of diabetic retinopathy. Lipodystrophy. Inj site reactions eg, redness, swelling, itching, pain & haematoma. Oedema. Urticaria, rash.

View ADR Monitoring Form

Drug Interactions

Deterioration in cardiac symptoms w/ pioglitazone. Reduced insulin requirement by oral hypoglycaemic agents, MAOIs, nonselective β-blocking agents, ACE inhibitors, salicylates, alcohol, anabolic steroids, sulphonamides. Increased insulin requirement by OCs, thiazides, glucocorticoids, thyroid hormones, β-sympathomimetics, growth hormone, danazol. Increased & decreased insulin requirement by octreotide/lanreotide. Intensified & prolonged hypoglycaemic effect w/ alcohol.

MIMS Class

Insulin Preparations

ATC Classification

A10AC01 - insulin (human) ; Belongs to the class of intermediate-acting insulins and analogues. Used in the treatment of diabetes.

Regulatory Classification

Presentation/Packing

Form

Insugen-N susp for inj (cartridge) 100 IU/mL

Packing/Price

3 mL x 5 × 1's

Insugen-N

insulin human, isophane

Manufacturer:

Biocon

Distributor:

Duopharma Marketing

Marketer:

Duopharma Marketing